Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Latest
Valuentum Commentary
Jan 17, 2016
Lots to Like About Intel’s 2016: 3D XPoint and Altera!
Intel finished 2015 on a strong note, but is it still headed in a positive direction? We had thought 2016 would be a breakout year for Intel, but will the company still deliver? Regardless, its share price is off to a rough start so far. Oct 25, 2015
Dividend Increases/Decreases for the Week Ending October 23
Let's take a look at companies raising/lowering their dividends this week. Mar 13, 2015
Intel Looks to Mobile to Overcome PC Weakness
Intel expects near-term revenue pressure, but the long-term remains bright. Jan 26, 2015
One Dividend Suspension and Five Other Disappointments
Expectations may be set a bit high heading into the fourth-quarter reporting period, and guidance for a number of firms has fallen short of expectations. Early signs of dividend cuts across the commodity sector are also materializing, and we may not have seen the worst yet. Oct 27, 2014
Dividend Increases for the Week Ending October 24
Let's take a look at dividend increases for the week ending October 24. Jun 22, 2014
Valuentum Economic Castle™ Rating Update
Members should expect the initial Economic Castle™ ratings. Apr 10, 2014
Encouraging News Regarding Worldwide PC Shipments
Intel continues its covert advance. Dec 9, 2013
PC Shipments Expected To Stabilize
We like the stabilizing outlook for PC shipments and view it as a positive for the entire PC supply chain. Feb 26, 2013
With M&A Popping, We Think More Deals Lie Ahead
Let's take a look at some potential targets. Aug 16, 2012
Hedge Fund Manager Bets Big on Health Insurers
Hedge fund manager David Einhorn established positions in several large health insurers. We like the move, but prefer the Healthcare Select Sector SPDR (XLV). Latest News and Media The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
